FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159881570> ?p ?o ?g. }

• W3159881570 endingPage "1993" @default.
• W3159881570 startingPage "1971" @default.
• W3159881570 abstract "Synthetic cyclin-dependent kinase (CDK) 4/6 inhibitors exert antitumor effects by forcing RB1 in unphosphorylated status, causing not only cell cycle arrest but also cellular senescence, apoptosis, and increased immunogenicity. These agents currently have an indication in advanced breast cancers and are in clinical trials for many other solid tumors. HCC is one of promising targets of CDK4/6 inhibitors. RB family dysfunction is often associated with the initiation of HCC; however, this is revivable, as RB family members are not frequently mutated or deleted in this malignancy.Loss of all Rb family members in transformation related protein 53 (Trp53)-/- mouse liver resulted in liver tumor reminiscent of human HCC, and re-expression of RB1 sensitized these tumors to a CDK4/6 inhibitor, palbociclib. Introduction of an unphosphorylatable form of RB1 (RB7LP) into multiple liver tumor cell lines induced effects similar to palbociclib. By screening for compounds that enhance the efficacy of RB7LP, we identified an I kappa B kinase (IKK)β inhibitor Bay 11-7082. Consistently, RB7LP expression and treatment with palbociclib enhanced IKKα/β phosphorylation and NF-κB activation. Combination therapy using palbociclib with Bay 11-7082 was significantly more effective in hepatoblastoma and HCC treatment than single administration. Moreover, blockade of IKK-NF-κB or AKT pathway enhanced effects of palbociclib on RB1-intact KRAS Kirsten rat sarcoma viral oncogene homolog mutated lung and colon cancers.In conclusion, CDK4/6 inhibitors have a potential to treat a wide variety of RB1-intact cancers including HCC when combined with an appropriate kinase inhibitor." @default.
• W3159881570 created "2021-05-10" @default.
• W3159881570 creator A5005051730 @default.
• W3159881570 creator A5006352924 @default.
• W3159881570 creator A5006787725 @default.
• W3159881570 creator A5008794738 @default.
• W3159881570 creator A5017882443 @default.
• W3159881570 creator A5018098557 @default.
• W3159881570 creator A5021958590 @default.
• W3159881570 creator A5026023167 @default.
• W3159881570 creator A5049376792 @default.
• W3159881570 creator A5050085904 @default.
• W3159881570 creator A5057494257 @default.
• W3159881570 creator A5057597665 @default.
• W3159881570 creator A5059542605 @default.
• W3159881570 creator A5065202965 @default.
• W3159881570 creator A5066277697 @default.
• W3159881570 creator A5073932562 @default.
• W3159881570 creator A5084118142 @default.
• W3159881570 creator A5084204471 @default.
• W3159881570 date "2021-08-25" @default.
• W3159881570 modified "2023-10-14" @default.
• W3159881570 title "Treatment of Retinoblastoma 1–Intact Hepatocellular Carcinoma With Cyclin‐Dependent Kinase 4/6 Inhibitor Combination Therapy" @default.
• W3159881570 cites W1578810612 @default.
• W3159881570 cites W1966918018 @default.
• W3159881570 cites W1970424369 @default.
• W3159881570 cites W1979721685 @default.
• W3159881570 cites W1995512508 @default.
• W3159881570 cites W2045844532 @default.
• W3159881570 cites W2070506594 @default.
• W3159881570 cites W2072863347 @default.
• W3159881570 cites W2100065945 @default.
• W3159881570 cites W2119171446 @default.
• W3159881570 cites W2139828679 @default.
• W3159881570 cites W2158771952 @default.
• W3159881570 cites W2159842699 @default.
• W3159881570 cites W2318725321 @default.
• W3159881570 cites W2323193108 @default.
• W3159881570 cites W2549164857 @default.
• W3159881570 cites W2568050301 @default.
• W3159881570 cites W2575938490 @default.
• W3159881570 cites W2750328162 @default.
• W3159881570 cites W2794558033 @default.
• W3159881570 cites W2891169646 @default.
• W3159881570 cites W2892043300 @default.
• W3159881570 cites W2902401096 @default.
• W3159881570 cites W2912400924 @default.
• W3159881570 cites W3004583890 @default.
• W3159881570 doi "https://doi.org/10.1002/hep.31872" @default.
• W3159881570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33931882" @default.
• W3159881570 hasPublicationYear "2021" @default.
• W3159881570 type Work @default.
• W3159881570 sameAs 3159881570 @default.
• W3159881570 citedByCount "18" @default.
• W3159881570 countsByYear W31598815702021 @default.
• W3159881570 countsByYear W31598815702022 @default.
• W3159881570 countsByYear W31598815702023 @default.
• W3159881570 crossrefType "journal-article" @default.
• W3159881570 hasAuthorship W3159881570A5005051730 @default.
• W3159881570 hasAuthorship W3159881570A5006352924 @default.
• W3159881570 hasAuthorship W3159881570A5006787725 @default.
• W3159881570 hasAuthorship W3159881570A5008794738 @default.
• W3159881570 hasAuthorship W3159881570A5017882443 @default.
• W3159881570 hasAuthorship W3159881570A5018098557 @default.
• W3159881570 hasAuthorship W3159881570A5021958590 @default.
• W3159881570 hasAuthorship W3159881570A5026023167 @default.
• W3159881570 hasAuthorship W3159881570A5049376792 @default.
• W3159881570 hasAuthorship W3159881570A5050085904 @default.
• W3159881570 hasAuthorship W3159881570A5057494257 @default.
• W3159881570 hasAuthorship W3159881570A5057597665 @default.
• W3159881570 hasAuthorship W3159881570A5059542605 @default.
• W3159881570 hasAuthorship W3159881570A5065202965 @default.
• W3159881570 hasAuthorship W3159881570A5066277697 @default.
• W3159881570 hasAuthorship W3159881570A5073932562 @default.
• W3159881570 hasAuthorship W3159881570A5084118142 @default.
• W3159881570 hasAuthorship W3159881570A5084204471 @default.
• W3159881570 hasConcept C104317684 @default.
• W3159881570 hasConcept C121608353 @default.
• W3159881570 hasConcept C124320809 @default.
• W3159881570 hasConcept C126322002 @default.
• W3159881570 hasConcept C184235292 @default.
• W3159881570 hasConcept C2775930923 @default.
• W3159881570 hasConcept C2776062698 @default.
• W3159881570 hasConcept C2776577112 @default.
• W3159881570 hasConcept C2778019345 @default.
• W3159881570 hasConcept C2779744173 @default.
• W3159881570 hasConcept C29537977 @default.
• W3159881570 hasConcept C502942594 @default.
• W3159881570 hasConcept C51853150 @default.
• W3159881570 hasConcept C530470458 @default.
• W3159881570 hasConcept C55493867 @default.
• W3159881570 hasConcept C71924100 @default.
• W3159881570 hasConcept C82495950 @default.
• W3159881570 hasConcept C86803240 @default.
• W3159881570 hasConcept C95444343 @default.
• W3159881570 hasConceptScore W3159881570C104317684 @default.
• W3159881570 hasConceptScore W3159881570C121608353 @default.
• W3159881570 hasConceptScore W3159881570C124320809 @default.

• next